• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[急性心肌梗死冠状动脉介入术后急性上消化道出血]

[Acute upper gastrointestinal bleeding after coronary intervention in acute myocardial infarction].

作者信息

Strobl Stefanie, Zuber-Jerger Ina

机构信息

Klinik und Poliklinik für Innere Medizin 1, Universitätsklinikum Regensburg, Regensburg, Germany.

出版信息

Med Klin (Munich). 2010 Apr;105(4):296-9. doi: 10.1007/s00063-010-1044-4.

DOI:10.1007/s00063-010-1044-4
PMID:20455053
Abstract

HISTORY AND ADMISSION FINDINGS

A 73-year-old man with NSTEMI (non-ST segment elevation myocardial infarction) underwent coronary angiography and an in-stent restenosis and thrombosis in ramus circumflexus was found. A drug-eluting stent (DES) was implanted. 12 h after intervention during threefold platelet inhibition the patient presented a gastrointestinal bleeding with melena and the hemoglobin level dropped from 15.3 g/dl to 9.7 g/dl.

INVESTIGATIONS

Blood tests revealed a considerable elevation of cardiac enzymes, troponin I, leukocytes and C-reactive protein but normal hemoglobin. In coronary angiography, the stent in ramus circumflexus was found to be occluded. Therefore, a percutaneous coronary intervention with implantation of a DES (Taxus) was performed. In gastroscopy, a 2.5-cm necrotic formation resembling a tumor with an oozing bleeding was identified. The bleeding was stopped after injection of adrenaline. Histological evaluation showed no criteria of malignancy.

TREATMENT AND COURSE

With high-dose proton pump blocker therapy, calculated Helicobacter pylori eradication with amoxicillin and clarithromycin, and cessation of NSAID (nonsteroidal anti-inflammatory drugs), the hemoglobin level was stable with 9.7 g/dl. No blood transfusion and no interruption of the dual platelet inhibition were necessary. In control gastroscopy, the initial endoscopically malignancy-suspicious formation presented as a small, superficial, healing ulcer.

CONCLUSION

Bleeding complications after stent implantation create a dilemma situation. The risk of a hemorrhagic shock by continuing platelet inhibition therapy and the risk of an acute stent thrombosis with interruption of the platelet inhibition should be carefully calculated considering individual facts and the guidelines.

摘要

病史及入院检查结果

一名73岁患有非ST段抬高型心肌梗死(NSTEMI)的男性接受了冠状动脉造影,发现其回旋支存在支架内再狭窄及血栓形成。随后植入了药物洗脱支架(DES)。介入治疗12小时后,在三联抗血小板抑制治疗期间,患者出现了伴有黑便的胃肠道出血,血红蛋白水平从15.3 g/dl降至9.7 g/dl。

检查

血液检查显示心肌酶、肌钙蛋白I、白细胞及C反应蛋白显著升高,但血红蛋白正常。冠状动脉造影显示回旋支支架闭塞。因此,进行了经皮冠状动脉介入治疗并植入了一枚DES(紫杉醇洗脱支架)。胃镜检查发现一个2.5厘米的坏死灶,类似肿瘤,有渗血,注射肾上腺素后出血停止。组织学评估未发现恶性肿瘤的特征。

治疗过程

采用大剂量质子泵阻滞剂治疗,联合阿莫西林和克拉霉素根除幽门螺杆菌,并停用非甾体抗炎药(NSAID),血红蛋白水平稳定在9.7 g/dl。无需输血,也无需中断双联抗血小板治疗。在胃镜复查中,最初内镜下怀疑为恶性的病灶呈现为一个小的、浅表的愈合性溃疡。

结论

支架植入后的出血并发症会造成两难局面。应根据个体情况和指南仔细权衡继续进行血小板抑制治疗导致出血性休克的风险以及中断血小板抑制治疗引发急性支架血栓形成的风险。

相似文献

1
[Acute upper gastrointestinal bleeding after coronary intervention in acute myocardial infarction].[急性心肌梗死冠状动脉介入术后急性上消化道出血]
Med Klin (Munich). 2010 Apr;105(4):296-9. doi: 10.1007/s00063-010-1044-4.
2
Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.经皮冠状动脉介入治疗后长期双联抗血小板治疗相关上消化道出血的风险与管理
Cardiovasc Revasc Med. 2009 Jan-Mar;10(1):36-44. doi: 10.1016/j.carrev.2008.11.001.
3
Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.有冠状动脉支架血栓形成风险的患者发生严重胃肠道出血。
Rev Cardiovasc Med. 2009 Winter;10(1):14-24.
4
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.急性心肌梗死后经皮冠状动脉介入治疗后支架血栓形成的频率及预测因素。
Circulation. 2011 Apr 26;123(16):1745-56. doi: 10.1161/CIRCULATIONAHA.110.981688. Epub 2011 Apr 11.
5
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.应用 SYNTAX 评分预测行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者 1 年临床结局:STRATEGY(单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死)和 MULTISTRATEGY(多中心评价单次大剂量替罗非班与阿昔单抗联合西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死研究)试验的一项亚研究。
JACC Cardiovasc Interv. 2011 Jan;4(1):66-75. doi: 10.1016/j.jcin.2010.09.017.
6
[Percutaneous coronary intervention in a patient with acute myeloid leukemia].[急性髓系白血病患者的经皮冠状动脉介入治疗]
Dtsch Med Wochenschr. 2012 May;137(21):1092-5. doi: 10.1055/s-0032-1305014. Epub 2012 May 15.
7
[Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].经皮冠状动脉介入治疗术后患者双联抗血小板治疗联合质子泵抑制剂安全性和有效性的Meta分析
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Feb 24;47(2):129-140. doi: 10.3760/cma.j.issn.0253-3758.2019.02.010.
8
Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.替罗非班作为ST段抬高型心肌梗死后植入冠状动脉药物洗脱支架的急诊手术患者替代治疗的短期随访
Coron Artery Dis. 2013 Sep;24(6):522-6. doi: 10.1097/MCA.0b013e3283645c79.
9
Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.冠状动脉支架置入术后接受双联抗血小板治疗患者的上消化道出血
Intern Med. 2009;48(19):1725-30. doi: 10.2169/internalmedicine.48.2031. Epub 2009 Oct 1.
10
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.尽管在急性心肌梗死中成功进行了机械干预,但导丝插入后持续无复流是一个早期且易于获得的死亡风险因素:来自 STRATEGY(单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死)和 MULTISTRATEGY(多中心评估单次大剂量替罗非班与阿昔单抗与西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死的研究)试验的汇总分析。
JACC Cardiovasc Interv. 2011 Jan;4(1):51-62. doi: 10.1016/j.jcin.2010.09.016.

引用本文的文献

1
Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome.改善急性冠脉综合征患者双联抗血小板治疗中质子泵抑制剂的使用。
BMJ Open Qual. 2022 Dec;11(4). doi: 10.1136/bmjoq-2022-001956.
2
Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy.接受冠状动脉支架植入术和双联抗血小板治疗的患者中与胃镜检查相关的不良心脏事件和出血并发症
Endosc Int Open. 2016 May;4(5):E527-33. doi: 10.1055/s-0042-102649. Epub 2016 Apr 28.

本文引用的文献

1
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.泮托拉唑和埃索美拉唑对氯吡格雷抑制血小板的影响。
Am Heart J. 2009 Jan;157(1):148.e1-5. doi: 10.1016/j.ahj.2008.09.017. Epub 2008 Nov 6.
2
[Percutaneous coronary interventions (PCI)].经皮冠状动脉介入治疗(PCI)
Clin Res Cardiol. 2008 Aug;97(8):513-47. doi: 10.1007/s00392-008-0697-y.
3
Coronary stent occlusion after platelet transfusion: a case series.
J Invasive Cardiol. 2007 Oct;19(10):E297-9.
4
Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study.经皮冠状动脉介入治疗后上消化道出血的预测因素和保护因素:一项病例对照研究。
Am J Gastroenterol. 2007 Nov;102(11):2411-6. doi: 10.1111/j.1572-0241.2007.01460.x. Epub 2007 Sep 10.
5
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.非ST段抬高型急性冠状动脉综合征诊断和治疗指南
Eur Heart J. 2007 Jul;28(13):1598-660. doi: 10.1093/eurheartj/ehm161. Epub 2007 Jun 14.
6
Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.单一及联合抗血栓治疗的使用与严重上消化道出血风险:基于人群的病例对照研究
BMJ. 2006 Oct 7;333(7571):726. doi: 10.1136/bmj.38947.697558.AE. Epub 2006 Sep 19.
7
Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction.急性心肌梗死经皮冠状动脉介入治疗后胃肠道出血的发生率及预后影响
Am J Cardiol. 2005 Jul 15;96(2):173-6. doi: 10.1016/j.amjcard.2005.03.038.
8
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events.肾功能不全患者的非ST段抬高型急性冠状动脉综合征:单用低分子量肝素或联合糖蛋白IIb/IIIa抑制剂对预后的益处。急性冠状动脉事件全球注册研究。
Eur Heart J. 2005 Nov;26(21):2285-93. doi: 10.1093/eurheartj/ehi337. Epub 2005 Jun 2.
9
Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
Am Heart J. 2005 Feb;149(2):217-26. doi: 10.1016/j.ahj.2004.08.038.
10
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.裸金属支架、西罗莫司支架或紫杉醇支架植入后血栓性支架闭塞的30天发生率及6个月临床结局
J Am Coll Cardiol. 2005 Mar 15;45(6):947-53. doi: 10.1016/j.jacc.2004.09.079.